產(chǎn)品(pǐn)中(zhōng)心(xīn)
相關(guān)產(chǎn)品
中(zhōng)藥標準品(pǐn)
|
產品編(biān)號 |
英文(wén)名(míng)稱 |
CAS號 |
包裝 |
|
Y3735 |
()-Huperzine A |
02518-79-6 |
可根(gēn)據(jù)客戶(hù)要求(qiú)訂(dìng)製(zhì) |
英(yīng)文(wén)名稱:()-Huperzine A
CAS號: 02518-79-6
分(fēn)析標準品(pǐn)
分(fēn)子(zǐ)式 C15H18N2O 分(fēn)子量242.32

基(jī)本(běn)信息:
溶(róng)解(jiě)性 易(yì)溶(róng)於(yú)氯仿(fǎng),溶於(yú)甲醇(chún),乙醇,微(wēi)溶於水(shuǐ)
存貯條(tiáo)件 儲存溫(wēn)度(dù)2-8℃
描述
別名 (-)-石杉鹼甲(jiǎ);(-)-Selagine
生化機理(lǐ)
Huperzine A, an active Lycopodium alkaloid extracted from traditional Chinese herb, is a potent, selective and reversible acetylcholinesterase (AChE) inhibitor and has been widely used in China for the treatment of Alzheimer's disease (AD). Huperzine A exhibited protective effects against d-gal-induced hepatotoxicity and inflamm-aging by inhibiting AChE activity and via the activation of the cholinergic anti-inflammatory pathway. The huperzine A mechanism might be involved in the inhibition of DAMPs-mediated NF-κB nuclear localization and activation. Huperzine A is a potential therapeutic agent for Alzheimer's disease.
應用 石杉(shān)鹼(jiǎn)甲不僅通過抑製膽鹼酯酶活性(xìng),還(huán)可以(yǐ)通過(guò)影響自(zì)由基(jī)係統,降低生長(cháng)抑(yì)素(sù),細胞內[Ca2+],穀氨酸含(hán)量,提高鈣調(tiáo)蛋白(CaM)和鈣(gài)調(tiáo)蛋白的(dí)信(xìn)使核(hé)糖(táng)核酸(CaM mRNA)表(biǎo)達水平等多(duō)種藥(yào)理(lǐ)機(jī)製,提高認知(zhī)功能和學習記(jì)憶(yì)能(néng)力(lì)。
存貯條(tiáo)件 儲存溫(wēn)度(dù)2-8℃
描述
別名 (-)-石杉鹼甲(jiǎ);(-)-Selagine
生化機理(lǐ)
Huperzine A, an active Lycopodium alkaloid extracted from traditional Chinese herb, is a potent, selective and reversible acetylcholinesterase (AChE) inhibitor and has been widely used in China for the treatment of Alzheimer's disease (AD). Huperzine A exhibited protective effects against d-gal-induced hepatotoxicity and inflamm-aging by inhibiting AChE activity and via the activation of the cholinergic anti-inflammatory pathway. The huperzine A mechanism might be involved in the inhibition of DAMPs-mediated NF-κB nuclear localization and activation. Huperzine A is a potential therapeutic agent for Alzheimer's disease.
應用 石杉(shān)鹼(jiǎn)甲不僅通過抑製膽鹼酯酶活性(xìng),還(huán)可以(yǐ)通過(guò)影響自(zì)由基(jī)係統,降低生長(cháng)抑(yì)素(sù),細胞內[Ca2+],穀氨酸含(hán)量,提高鈣調(tiáo)蛋白(CaM)和鈣(gài)調(tiáo)蛋白的(dí)信(xìn)使核(hé)糖(táng)核酸(CaM mRNA)表(biǎo)達水平等多(duō)種藥(yào)理(lǐ)機(jī)製,提高認知(zhī)功能和學習記(jì)憶(yì)能(néng)力(lì)。
- 上一(yī)條:二(èr)氫(qīng)黃酮(tóng)甙
- 下一條(tiáo):橙(chéng)皮素
